Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2012 Jan 11;68(Pt 2):o333–o334. doi: 10.1107/S1600536811055516

3,12-Diaza-6,9-diazo­nia-2,13-dioxotetra­decane bis­(perchlorate)

Tilo Söhnel a,*, Kathrin A Wichmann a,b, Thomas Doert c, Garth J S Cooper b,d,e
PMCID: PMC3275019  PMID: 22346964

Abstract

The crystal structure of the title diprotonated diacetyl­triethyl­ene­tetra­mine (DAT) perchorate salt, C10H24N4O2 2+·2ClO4 , can be described as a three-dimensional assembly of alternating layers consisting of diprotonated diacetyl­triethyl­ene­tetra­mine (H2DAT)2+ strands along [100] and the anionic species ClO4 . The (H2DAT)2+ cations in the strands are connected via N—H⋯O hydrogen bonding between the acetyl groups and the amine groups of neighbouring (H2DAT)2+ cations. Layers of (H2DAT)2+ strands and perchlorate anions are connected by a network of hydrogen bonds between the NH and NH2 groups and the O atoms of the perchlorate anion. The asymmetric unit consits of one perchlorate anion in a general position, as well as of one cation that is located on a center of inversion.

Related literature

For background to pharmaceutical chelating agents in the treatment of diabetes, see: Cooper et al. (2004); Gong et al. (2006, 2008); Jüllig et al. (2007); Lu et al. (2010). For the detection of a new group of TETA metabolites, see: Lu et al. (2007). For the preparation and characterization of DAT mono- and dihydro­chloride salts, see: Jonas et al. (2006); Wichmann et al. (2011). For related structures, see: Elaoud et al. (1999); Fu et al. (2005); Ilioudis et al. (2000, 2002); Ilioudis & Steed (2003); Wichmann et al. (2007). graphic file with name e-68-0o333-scheme1.jpg

Experimental

Crystal data

  • C10H24N4O2 2+·2ClO4

  • M r = 431.23

  • Monoclinic, Inline graphic

  • a = 6.0888 (5) Å

  • b = 10.9415 (9) Å

  • c = 14.8160 (11) Å

  • β = 110.846 (6)°

  • V = 922.44 (13) Å3

  • Z = 2

  • Mo Kα radiation

  • μ = 0.41 mm−1

  • T = 150 K

  • 0.45 × 0.35 × 0.17 mm

Data collection

  • Stoe IPDS II diffractometer

  • Absorption correction: numerical (X-RED32; Stoe & Cie, 2001) T min = 0.837, T max = 0.936

  • 11528 measured reflections

  • 2113 independent reflections

  • 1624 reflections with I > 2σ(I)

  • R int = 0.114

Refinement

  • R[F 2 > 2σ(F 2)] = 0.039

  • wR(F 2) = 0.087

  • S = 1.03

  • 2113 reflections

  • 120 parameters

  • H-atom parameters constrained

  • Δρmax = 0.38 e Å−3

  • Δρmin = −0.42 e Å−3

Data collection: X-AREA (Stoe & Cie, 2002); cell refinement: X-AREA; data reduction: X-AREA; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: VESTA (Momma & Izumi, 2011); software used to prepare material for publication: publCIF (Westrip, 2010).

Supplementary Material

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811055516/nc2261sup1.cif

e-68-0o333-sup1.cif (19KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811055516/nc2261Isup2.hkl

e-68-0o333-Isup2.hkl (104KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
N3—H3⋯O4 0.88 2.12 2.989 (2) 167
N6—H6A⋯O1i 0.92 1.77 2.6745 (19) 168
N6—H6B⋯O2ii 0.92 2.13 2.9265 (17) 145
N6—H6B⋯O5ii 0.92 2.40 3.2141 (19) 147

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Acknowledgments

We acknowledge support from the following funding sources: Endocore Research Associates; the Maurice and Phyllis Paykel Trust; Lottery Health (New Zealand); the Auckland Medical Research Foundation; the University of Auckland; the Department of Education (New Zealand) through a grant to the Maurice Wilkins Centre of Excellence for Mol­ecular Biodiscovery; Protemix Corporation Ltd; and by program grants from the Foundation for Research Science and Technology, New Zealand and from the Health Research Council of New Zealand.

supplementary crystallographic information

Comment

As part of a larger project focusing on TETA and its metabolites as pharmaceutical chelating agents in Diabetes treatment (Cooper et al., 2004, Gong et al. 2006, 2008, Jüllig et al. 2007, Lu et al. 2010), we previously published the detection of a new group of TETA metabolites, N1-Monoacetyltriethylenetetramine (MAT) and the N1, N10-Diacetyltriethylenetetramine (DAT) (Lu et al. 2007), as well as just recently the development of a new selective synthetic route and the characterization of the DAT mono- and dihydrochloride salts (Wichmann et al., 2011).

TETA and its metabolites belong into the polyamine family, ambivalent and multidentate ligands, which are well known for their ability to form a variety of interesting open-chain, macrocyclic and three-dimensional architectures. TETA salts exist in variable protonation states with different anionic species (Ilioudis, et al. 2000, 2002, 2003, Elaoud et al. 1999, Fu et al. 2005, Wichmann et al. 2007). Therefore, we investigated the metabolite forms MAT and DAT towards their protonation and complexation behaviour (Wichmann et al., 2011). The obtained crystal structure of the new DAT salt [(H2DAT) * 2 ClO4] is described in this paper.

The (H2DAT)2+ cations are arranged as a linear symmetric chain with the terminal NH—CO—CH3 groups in trans-position to each other (Fig. 1).

The crystal structure consists of a three-dimensional-network, containing alternating assembly of two-dimensional-layers of (H2DAT)2+ cations (Fig. 2) and the ClO4- anions. The (H2DAT)2+ cations form linear strands along [100] (Fig. 3), connected via hydrogen bonding between the acetyl groups and the amine groups of neighbouring (H2DAT)2+ cations, with a C2=O1 ··· H6A/N6 distance of 1.767 (1) Å. These linear strands of the (H2DAT)2+ cations form two-dimensional-layers in the (001) plane. However, the two-dimensional-layers of (H2DAT)2+ cations and the perchlorate anions were stabilized by a network of intermolecular hydrogen bonds between the NH– and NH2-groups and the oxygen atoms of the perchlorate anion, with N6—H6B···O2—Cl1—O4···H3—N3 between 2.126 (1) Å and 2.125 (1) Å, (Table 1). The terminal NH-groups of a (H2DAT)2+ cation binds to an O-atom of a perchlorate anion, which itself bound to an internal NH-group of another (H2DAT)2+ cation and vice versa. Therefore each (H2DAT)2+ cation is connected to four different (H2DAT)2+ cations, two from the above and two from the below layer.

Experimental

The DAT * 2 HCl powder material was synthesized by CarboGen, Switzerland according to literature procedure (Jonas et al. 2006, Wichmann et al. 2011). Cu(ClO4)2 is commercially available and was used as received. Crystals of the title compound were grown by slow evaporation of an aqueous solution of DAT * 2 HCl and Cu(ClO4)2 in stoichiometric ratio in water over a period of 6 weeks.

Refinement

H atoms bonded to C and N atoms were positioned geometrically (C—H = 0.98–0.99 Å, N—H = 0.88–0.92 Å) and refined using a riding-model approximation, with Uiso(H) = 1.5 Ueq(C, N).

Figures

Fig. 1.

Fig. 1.

Crystal structure of the title compound with labeling and displacement ellipsoids drawn at the 75% probabiliyt level. [symmetry code: (i) -x, -y - z + 1].

Fig. 2.

Fig. 2.

Crystal structure of the title compound with view along the a axis. Hydrogen bonding interactions are shown as dashed lines.

Fig. 3.

Fig. 3.

The strands of (H2DAT)2+ cations viewed along the a axis. The dashed bonds indicate the hydrogen bonds.

Crystal data

C10H24N4O22+·2ClO4 F(000) = 452
Mr = 431.23 Dx = 1.553 Mg m3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybc Cell parameters from 12054 reflections
a = 6.0888 (5) Å θ = 4.7–59.0°
b = 10.9415 (9) Å µ = 0.41 mm1
c = 14.8160 (11) Å T = 150 K
β = 110.846 (6)° Not regular, colourless
V = 922.44 (13) Å3 0.45 × 0.35 × 0.17 mm
Z = 2

Data collection

Stoe IPDS II diffractometer 2113 independent reflections
Radiation source: fine-focus sealed tube 1624 reflections with I > 2σ(I)
graphite Rint = 0.114
Image plate detector scans θmax = 27.5°, θmin = 2.4°
Absorption correction: numerical (X-RED32; Stoe & Cie, 2001) h = −7→6
Tmin = 0.837, Tmax = 0.936 k = −14→14
11528 measured reflections l = −19→19

Refinement

Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.039 H-atom parameters constrained
wR(F2) = 0.087 w = 1/[σ2(Fo2) + (0.0435P)2 + 0.0412P] where P = (Fo2 + 2Fc2)/3
S = 1.03 (Δ/σ)max = 0.001
2113 reflections Δρmax = 0.38 e Å3
120 parameters Δρmin = −0.42 e Å3
0 restraints Extinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methods Extinction coefficient: 0.0082 (19)

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
O1 0.7492 (2) −0.27758 (14) 0.49858 (8) 0.0292 (3)
N3 0.4849 (2) −0.35281 (14) 0.55667 (8) 0.0203 (3)
H3 0.4552 −0.3783 0.6075 0.030*
N6 0.1286 (2) −0.15588 (13) 0.49690 (8) 0.0180 (3)
H6A 0.0102 −0.2008 0.5058 0.027*
H6B 0.2493 −0.1497 0.5556 0.027*
C1 0.8854 (3) −0.3315 (2) 0.66635 (12) 0.0306 (4)
H1A 0.9869 −0.4013 0.6669 0.046*
H1B 0.8082 −0.3455 0.7133 0.046*
H1C 0.9805 −0.2570 0.6835 0.046*
C2 0.7025 (3) −0.31761 (17) 0.56731 (10) 0.0212 (3)
C4 0.2944 (3) −0.35009 (17) 0.46258 (10) 0.0218 (4)
H4A 0.1589 −0.3965 0.4668 0.033*
H4B 0.3476 −0.3914 0.4145 0.033*
C5 0.2149 (3) −0.22157 (17) 0.42777 (10) 0.0211 (3)
H5A 0.3478 −0.1757 0.4205 0.032*
H5B 0.0875 −0.2255 0.3637 0.032*
C7 0.0392 (3) −0.03159 (17) 0.46280 (11) 0.0230 (4)
H7A −0.0947 −0.0376 0.4008 0.035*
H7B 0.1647 0.0169 0.4518 0.035*
Cl1 0.43802 (6) −0.55724 (4) 0.77065 (2) 0.02264 (14)
O2 0.4296 (2) −0.55967 (14) 0.86654 (8) 0.0337 (3)
O3 0.2285 (3) −0.60503 (17) 0.70295 (10) 0.0478 (4)
O4 0.4650 (3) −0.43253 (15) 0.74660 (10) 0.0461 (4)
O5 0.6382 (3) −0.62675 (18) 0.77258 (10) 0.0507 (5)

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
O1 0.0253 (6) 0.0377 (9) 0.0282 (5) −0.0049 (6) 0.0139 (5) −0.0020 (5)
N3 0.0192 (6) 0.0211 (8) 0.0200 (6) 0.0012 (6) 0.0062 (5) 0.0024 (5)
N6 0.0164 (6) 0.0183 (7) 0.0180 (5) 0.0012 (6) 0.0044 (4) 0.0009 (5)
C1 0.0222 (8) 0.0346 (12) 0.0290 (8) 0.0027 (8) 0.0020 (6) 0.0014 (8)
C2 0.0204 (7) 0.0180 (9) 0.0251 (7) 0.0018 (7) 0.0081 (6) −0.0024 (6)
C4 0.0192 (7) 0.0211 (9) 0.0226 (7) −0.0001 (7) 0.0041 (5) −0.0031 (6)
C5 0.0214 (7) 0.0231 (9) 0.0185 (6) 0.0032 (7) 0.0069 (5) 0.0001 (6)
C7 0.0251 (8) 0.0201 (9) 0.0265 (7) 0.0083 (7) 0.0124 (6) 0.0060 (6)
Cl1 0.0200 (2) 0.0276 (2) 0.01913 (18) 0.00163 (17) 0.00557 (13) 0.00246 (15)
O2 0.0382 (7) 0.0424 (9) 0.0237 (6) 0.0036 (7) 0.0150 (5) 0.0075 (5)
O3 0.0355 (8) 0.0518 (11) 0.0400 (7) −0.0072 (8) −0.0063 (6) −0.0065 (7)
O4 0.0564 (9) 0.0378 (10) 0.0441 (7) −0.0072 (8) 0.0180 (7) 0.0166 (7)
O5 0.0381 (8) 0.0661 (13) 0.0463 (8) 0.0256 (8) 0.0130 (6) −0.0092 (8)

Geometric parameters (Å, °)

O1—C2 1.231 (2) C4—C5 1.517 (2)
N3—C2 1.334 (2) C4—H4A 0.9900
N3—C4 1.4622 (17) C4—H4B 0.9900
N3—H3 0.8800 C5—H5A 0.9900
N6—C7 1.485 (2) C5—H5B 0.9900
N6—C5 1.492 (2) C7—C7i 1.515 (3)
N6—H6A 0.9200 C7—H7A 0.9900
N6—H6B 0.9200 C7—H7B 0.9900
C1—C2 1.501 (2) Cl1—O3 1.4129 (13)
C1—H1A 0.9800 Cl1—O5 1.4284 (15)
C1—H1B 0.9800 Cl1—O4 1.4344 (16)
C1—H1C 0.9800 Cl1—O2 1.4401 (12)
C2—N3—C4 121.60 (13) N3—C4—H4B 109.0
C2—N3—H3 119.2 C5—C4—H4B 109.0
C4—N3—H3 119.2 H4A—C4—H4B 107.8
C7—N6—C5 112.56 (12) N6—C5—C4 111.17 (13)
C7—N6—H6A 109.1 N6—C5—H5A 109.4
C5—N6—H6A 109.1 C4—C5—H5A 109.4
C7—N6—H6B 109.1 N6—C5—H5B 109.4
C5—N6—H6B 109.1 C4—C5—H5B 109.4
H6A—N6—H6B 107.8 H5A—C5—H5B 108.0
C2—C1—H1A 109.5 N6—C7—C7i 110.03 (16)
C2—C1—H1B 109.5 N6—C7—H7A 109.7
H1A—C1—H1B 109.5 C7i—C7—H7A 109.7
C2—C1—H1C 109.5 N6—C7—H7B 109.7
H1A—C1—H1C 109.5 C7i—C7—H7B 109.7
H1B—C1—H1C 109.5 H7A—C7—H7B 108.2
O1—C2—N3 121.11 (13) O3—Cl1—O5 111.45 (11)
O1—C2—C1 122.39 (15) O3—Cl1—O4 109.27 (10)
N3—C2—C1 116.49 (14) O5—Cl1—O4 109.82 (11)
N3—C4—C5 113.08 (13) O3—Cl1—O2 110.69 (9)
N3—C4—H4A 109.0 O5—Cl1—O2 107.47 (8)
C5—C4—H4A 109.0 O4—Cl1—O2 108.06 (10)

Symmetry codes: (i) −x, −y, −z+1.

Hydrogen-bond geometry (Å, °)

D—H···A D—H H···A D···A D—H···A
N3—H3···O4 0.88 2.12 2.989 (2) 167
N6—H6A···O1ii 0.92 1.77 2.6745 (19) 168
N6—H6B···O2iii 0.92 2.13 2.9265 (17) 145
N6—H6B···O5iii 0.92 2.40 3.2141 (19) 147

Symmetry codes: (ii) x−1, y, z; (iii) −x+1, y+1/2, −z+3/2.

Footnotes

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: NC2261).

References

  1. Cooper, G. J. S., Phillips, A. R. J., Choong, S. Y., Leonard, B. L., Crossman, D. J., Brunton, D. H., Saafi, E. L., Dissanayake, A. M., Cowan, B. R., Young, A. A., Occleshaw, C. J., Chan, Y.-K., Leahy, F. E., Keogh, G. F., Gamble, G. D., Allen, G. R., Pope, A. J., Boyd, P. D. W., Poppitt, S. D., Borg, T. K., Doughty, R. N. & Baker, J. R. (2004). Diabetes, 53, 2501–2508. [DOI] [PubMed]
  2. Elaoud, Z., Kamoun, S. & Mhiri, T. (1999). J. Chem. Crystallogr. 29, 1287–1290.
  3. Fu, Y.-L., Xu, Z.-W., Ren, J.-L. & Ng, S. W. (2005). Acta Cryst. E61, o774–o775.
  4. Gong, D., Lu, J., Chen, X., Choong, S. Y., Zhang, S., Chan, Y.-K., Glyn-Jones, S., Gamble, G. D., Phillips, A. R. J. & Cooper, G. J. S. (2006). Mol. Pharmacol. 70, 2045–2051. [DOI] [PubMed]
  5. Gong, D., Lu, J., Chen, X., Reddy, S., Crossman, D. J., Glyn-Jones, S., Choong, Y.-S., Kennedy, J., Barry, B., Zhang, S., Chan, Y.-K., Ruggiero, K., Phillips, A. R. J. & Cooper, G. J. S. (2008). Diabetologia, 51, 1741–1751. [DOI] [PubMed]
  6. Ilioudis, C. A., Georganopoulou, D. G. & Steed, J. W. (2002). CrystEngComm, 4, 26–36.
  7. Ilioudis, C. A., Hancock, K. S. B., Georganopoulou, D. G. & Steed, J. W. (2000). New J. Chem. 24, 787–798.
  8. Ilioudis, C. A. & Steed, J. W. (2003). J. Supramol. Chem. 1, 165–187.
  9. Jonas, M., Vaulont, I., Soi, A. & Schmidt, G. (2006). US Patent Appl. 20060041170.
  10. Jüllig, M., Chen, X., Hickey, A. J., Crossman, D. J., Xu, A., Wang, Y., Greenwood, D. R., Choong, Y. S., Schönberger, S. J., Middleditch, M. J., Phillips, A. R. J. & Cooper, G. J. S. (2007). Proteomics Clin. Appl. 1, 387–399. [DOI] [PubMed]
  11. Lu, J., Chan, Y.-K., Poppitt, S. D., Othman, A. A. & Cooper, G. J. S. (2007). J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 859, 62–68. [DOI] [PubMed]
  12. Lu, J., Gong, D., Choong, S. Y., Xu, H., Chan, Y. K., Chen, X., Fitzpatrick, S., Glyn-Jones, S., Zhang, S., Nakamura, T., Ruggiero, K., Obolonkin, V., Poppitt, S. D., Phillips, A. R. J. & Cooper, G. J. S. (2010). Diabetologia, 53, 1217–1226. [DOI] [PubMed]
  13. Momma, K. & Izumi, F. (2011). J. Appl. Cryst. 44, 1272–1276.
  14. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  15. Stoe & Cie (2001). X-RED32 Stoe & Cie GmbH, Darmstadt, Germany.
  16. Stoe & Cie (2002). X-AREA Stoe & Cie GmbH, Darmstadt, Germany.
  17. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.
  18. Wichmann, K. A., Boyd, P. D. W., Söhnel, T., Allen, G. R., Phillips, A. R. J. & Cooper, G. J. S. (2007). Cryst. Growth Des. 7, 1844–1850.
  19. Wichmann, K. A., Söhnel, T. & Cooper, G. J. S. (2011). J. Mol. Struct. doi:10.1016/j.molstruc.2011.12.020. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811055516/nc2261sup1.cif

e-68-0o333-sup1.cif (19KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811055516/nc2261Isup2.hkl

e-68-0o333-Isup2.hkl (104KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES